| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.19 | 0.004 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.46 | 0.008 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.1 | 0.008 |